Literature DB >> 29700491

Anticancer drugs: Flipping the switch for selective GSK3 inhibition.

Katie Kingwell.   

Abstract

Year:  2018        PMID: 29700491     DOI: 10.1038/nrd.2018.63

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia.

Authors:  Florence F Wagner; Lina Benajiba; Arthur J Campbell; Michel Weïwer; Joshua R Sacher; Jennifer P Gale; Linda Ross; Alexandre Puissant; Gabriela Alexe; Amy Conway; Morgan Back; Yana Pikman; Ilene Galinsky; Daniel J DeAngelo; Richard M Stone; Taner Kaya; Xi Shi; Matthew B Robers; Thomas Machleidt; Jennifer Wilkinson; Olivier Hermine; Andrew Kung; Adam J Stein; Damodharan Lakshminarasimhan; Michael T Hemann; Edward Scolnick; Yan-Ling Zhang; Jen Q Pan; Kimberly Stegmaier; Edward B Holson
Journal:  Sci Transl Med       Date:  2018-03-07       Impact factor: 17.956

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.